| Year |
Citation |
Score |
| 2021 |
Ji K, Zhao Z, Sameni M, Moin K, Xu Y, Gillies RJ, Sloane BF, Mattingly RR. Modeling Tumor: Lymphatic Interactions in Lymphatic Metastasis of Triple Negative Breast Cancer. Cancers. 13. PMID 34885152 DOI: 10.3390/cancers13236044 |
0.311 |
|
| 2020 |
Thakur A, Kondadasula SV, Ji K, Schalk DL, Bliemeister E, Ung J, Aboukameel A, Casarez E, Sloane BF, Lum LG. Anti-tumor and immune modulating activity of T cell induced tumor-targeting effectors (TITE). Cancer Immunology, Immunotherapy : Cii. PMID 32865605 DOI: 10.1007/S00262-020-02692-8 |
0.443 |
|
| 2019 |
Ji K, Sameni M, Osuala K, Moin K, Mattingly RR, Sloane BF. Spatio-temporal modeling and live-cell imaging of proteolysis in the 4D microenvironment of breast cancer. Cancer Metastasis Reviews. PMID 31605250 DOI: 10.1007/S10555-019-09810-8 |
0.439 |
|
| 2019 |
Osuala KO, Ji K, Mattingly RR, Sloane BF. Breast Cancer: Proteolysis and Migration. Advances in Experimental Medicine and Biology. 1152: 401-411. PMID 31456196 DOI: 10.1007/978-3-030-20301-6_21 |
0.505 |
|
| 2019 |
Ji K, Mayernik L, Moin K, Sloane BF. Acidosis and proteolysis in the tumor microenvironment. Cancer Metastasis Reviews. PMID 31069574 DOI: 10.1007/S10555-019-09796-3 |
0.469 |
|
| 2019 |
Thakur A, Yarlagadda S, Ji K, Schalk DL, Ung J, Bliemeister ET, Aboukameel A, Casarez E, Sloane BF, Lum LG. Abstract 5036: Induction of highly efficacious anti-tumor activity and modulation of tumor microenvironment: Cell-free off the shelf therapeutic modality Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-5036 |
0.426 |
|
| 2018 |
Shah S, Brock EJ, Jackson RM, Ji K, Boerner JL, Sloane BF, Mattingly RR. Downregulation of Rap1Gap: A Switch from DCIS to Invasive Breast Carcinoma via ERK/MAPK Activation. Neoplasia (New York, N.Y.). 20: 951-963. PMID 30144784 DOI: 10.1016/J.Neo.2018.07.002 |
0.433 |
|
| 2018 |
Brock EJ, Ji K, Shah S, Mattingly RR, Sloane BF. In Vitro Models for Studying Invasive Transitions of Ductal Carcinoma In Situ. Journal of Mammary Gland Biology and Neoplasia. PMID 30056557 DOI: 10.1007/S10911-018-9405-3 |
0.392 |
|
| 2018 |
Brock EJ, Jackson R, Boerner JL, Li Q, Sloane BF, Mattingly RR. Abstract B14: Sprouty4 regulates the transition to invasive breast ductal carcinoma through ERK/MAPK signaling Molecular Cancer Research. 16. DOI: 10.1158/1557-3125.Advbc17-B14 |
0.399 |
|
| 2018 |
Ji K, Zhao Z, Moin K, Xu Y, Gillies RJ, Mattingly RR, Sloane BF. Abstract 2131: Paracrine cytokine pathways mediate metastasis of breast cancer to lymphatics Cancer Research. 78: 2131-2131. DOI: 10.1158/1538-7445.Am2018-2131 |
0.456 |
|
| 2017 |
Duivenvoorden HM, Rautela J, Edgington-Mitchell LE, Spurling A, Greening DW, Nowell CJ, Molloy TJ, Robbins E, Brockwell NK, Lee CS, Chen M, Holliday A, Selinger CI, Hu M, Britt KL, ... ... Sloane BF, et al. Myoepithelial cell-specific expression of stefin A as a suppressor of early breast cancer invasion. The Journal of Pathology. PMID 29086922 DOI: 10.1002/Path.4990 |
0.471 |
|
| 2017 |
Sameni M, Cavallo-Medved D, Franco OE, Chalasani A, Ji K, Aggarwal N, Anbalagan A, Chen X, Mattingly RR, Hayward SW, Sloane BF. Pathomimetic avatars reveal divergent roles of microenvironment in invasive transition of ductal carcinoma in situ. Breast Cancer Research : Bcr. 19: 56. PMID 28506312 DOI: 10.1186/S13058-017-0847-0 |
0.383 |
|
| 2017 |
Chalasani A, Ji K, Sameni M, Mazumder SH, Xu Y, Moin K, Sloane BF. Live-Cell Imaging of Protease Activity: Assays to Screen Therapeutic Approaches. Methods in Molecular Biology (Clifton, N.J.). 1574: 215-225. PMID 28315254 DOI: 10.1007/978-1-4939-6850-3_16 |
0.458 |
|
| 2017 |
Jackson RM, Brock EJ, Shah S, Sameni M, Sloane BF, Li Q, Mattingly RR. Abstract B28: Induced expression of Sprouty4 in breast invasive ductal carcinoma cells inhibits ERK MAP kinase and reduces malignant phenotype Clinical Cancer Research. 23. DOI: 10.1158/1557-3265.Pmccavuln16-B28 |
0.429 |
|
| 2016 |
Ji K, Heyza J, Cavallo-Medved D, Sloane BF. Pathomimetic cancer avatars for live-cell imaging of protease activity. Biochimie. 122: 68-76. PMID 26375517 DOI: 10.1016/J.Biochi.2015.09.015 |
0.48 |
|
| 2016 |
Ji K, Zhao Z, Moin K, Xu Y, Sloane BF. Abstract B65: Live-cell imaging of 3D/4D parallel co-cultures of breast carcinoma cells and breast fibroblasts in tissue architecture and microenvironment engineering (TAME) chambers Molecular Cancer Research. 14. DOI: 10.1158/1557-3125.Advbc15-B65 |
0.471 |
|
| 2016 |
Tovar EA, Sameni M, Essenburg CJ, Chalasani A, Linklater ES, Cherba DM, Anbalagan A, Winn ME, Sloane BF, Graveel CR. Abstract B19: MET and IL6 signaling in triple-negative breast cancer Molecular Cancer Research. 14. DOI: 10.1158/1557-3125.Advbc15-B19 |
0.375 |
|
| 2016 |
Brock EJ, Jackson R, Shah S, Li Q, Sameni M, Krawetz SA, Mao S, Sloane BF, Mattingly RR. Abstract 4560: Induced Sprouty4 expression in breast invasive ductal carcinoma cells downregulates ERK/MAPK activity and restores an epithelial-like phenotype Cancer Research. 76: 4560-4560. DOI: 10.1158/1538-7445.Am2016-4560 |
0.398 |
|
| 2015 |
Ramalho SD, Sharma R, White JK, Aggarwal N, Chalasani A, Sameni M, Moin K, Vieira PC, Turro C, Kodanko JJ, Sloane BF. Imaging Sites of Inhibition of Proteolysis in Pathomimetic Human Breast Cancer Cultures by Light-Activated Ruthenium Compound. Plos One. 10: e0142527. PMID 26562785 DOI: 10.1371/Journal.Pone.0142527 |
0.401 |
|
| 2015 |
Aggarwal N, Santiago AM, Kessel D, Sloane BF. Photodynamic therapy as an effective therapeutic approach in MAME models of inflammatory breast cancer. Breast Cancer Research and Treatment. PMID 26502410 DOI: 10.1007/S10549-015-3618-6 |
0.355 |
|
| 2015 |
Sameni M, Tovar EA, Essenburg C, Chalasani A, Linklater ES, Borgman A, Cherba DM, Anbalagan A, Winn ME, Graveel CR, Sloane BF. Cabozantinib (XL184) inhibits growth and invasion of preclinical TNBC models. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 26432786 DOI: 10.1158/1078-0432.Ccr-15-0187 |
0.326 |
|
| 2015 |
Osuala KO, Sameni M, Shah S, Aggarwal N, Simonait ML, Franco OE, Hong Y, Hayward SW, Behbod F, Mattingly RR, Sloane BF. Il-6 signaling between ductal carcinoma in situ cells and carcinoma-associated fibroblasts mediates tumor cell growth and migration. Bmc Cancer. 15: 584. PMID 26268945 DOI: 10.1186/S12885-015-1576-3 |
0.414 |
|
| 2015 |
Weber E, Barbulescu E, Medek R, Reinheckel T, Sameni M, Anbalagan A, Moin K, Sloane BF. Cathepsin B-deficient mice as source of monoclonal anti-cathepsin B antibodies. Biological Chemistry. 396: 277-81. PMID 25205719 DOI: 10.1515/Hsz-2014-0191 |
0.343 |
|
| 2015 |
Ibrahim SA, Elghonaimy EA, El-Shinawi M, El-Halawany M, Nouh MA, El-Mamlouk T, Sloane BF, Mohamed MM. Abstract 430: MCP-1/CCL2 and IL-8 regulate proteolytic activity of triple negative inflammatory breast cancer via cathepsin B, ERK1/2, JAK1 and Src signaling pathways Cancer Research. 75: 430-430. DOI: 10.1158/1538-7445.Am2015-430 |
0.413 |
|
| 2014 |
Osuala KO, Sloane BF. Many Roles of CCL20: Emphasis on Breast Cancer. Postdoc Journal : a Journal of Postdoctoral Research and Postdoctoral Affairs. 2: 7-16. PMID 27631019 DOI: 10.14304/Surya.Jpr.V2N3.2 |
0.421 |
|
| 2014 |
Tan CD, Hobbs C, Sameni M, Sloane BF, Stutts MJ, Tarran R. Cathepsin B contributes to Na+ hyperabsorption in cystic fibrosis airway epithelial cultures. The Journal of Physiology. 592: 5251-68. PMID 25260629 DOI: 10.1113/Jphysiol.2013.267286 |
0.307 |
|
| 2014 |
Aggarwal N, Sloane BF. Cathepsin B: multiple roles in cancer. Proteomics. Clinical Applications. 8: 427-37. PMID 24677670 DOI: 10.1002/Prca.201300105 |
0.496 |
|
| 2014 |
Banda M, Speyer CL, Semma SN, Osuala KO, Kounalakis N, Torres Torres KE, Barnard NJ, Kim HJ, Sloane BF, Miller FR, Goydos JS, Gorski DH. Metabotropic glutamate receptor-1 contributes to progression in triple negative breast cancer. Plos One. 9: e81126. PMID 24404125 DOI: 10.1371/Journal.Pone.0081126 |
0.393 |
|
| 2014 |
Mohamed MM, El-Ghonaimy EA, Nouh MA, Schneider RJ, Sloane BF, El-Shinawi M. Cytokines secreted by macrophages isolated from tumor microenvironment of inflammatory breast cancer patients possess chemotactic properties. The International Journal of Biochemistry & Cell Biology. 46: 138-47. PMID 24291763 DOI: 10.1016/J.Biocel.2013.11.015 |
0.407 |
|
| 2014 |
Bengsch F, Buck A, Günther SC, Seiz JR, Tacke M, Pfeifer D, von Elverfeldt D, Sevenich L, Hillebrand LE, Kern U, Sameni M, Peters C, Sloane BF, Reinheckel T. Cell type-dependent pathogenic functions of overexpressed human cathepsin B in murine breast cancer progression. Oncogene. 33: 4474-84. PMID 24077280 DOI: 10.1038/Onc.2013.395 |
0.537 |
|
| 2014 |
Shah S, Osuala K, Mao S, Li Q, Sloane B, Krawetz S, Mattingly RR. Abstract 3150: Exploring the role of Rap1Gap in the progression from DCIS to invasive breast carcinoma Cancer Research. 74: 3150-3150. DOI: 10.1158/1538-7445.Am2014-3150 |
0.458 |
|
| 2014 |
Kessel D, Aggarwal N, Sloane BF. Increased efficacy of photodynamic therapy via sequential targeting Progress in Biomedical Optics and Imaging - Proceedings of Spie. 8931. DOI: 10.1117/12.2042421 |
0.357 |
|
| 2013 |
Rothberg JM, Bailey KM, Wojtkowiak JW, Ben-Nun Y, Bogyo M, Weber E, Moin K, Blum G, Mattingly RR, Gillies RJ, Sloane BF. Acid-mediated tumor proteolysis: contribution of cysteine cathepsins. Neoplasia (New York, N.Y.). 15: 1125-37. PMID 24204192 DOI: 10.1593/Neo.13946 |
0.729 |
|
| 2013 |
Ruffell B, Affara NI, Cottone L, Junankar S, Johansson M, DeNardo DG, Korets L, Reinheckel T, Sloane BF, Bogyo M, Coussens LM. Cathepsin C is a tissue-specific regulator of squamous carcinogenesis. Genes & Development. 27: 2086-98. PMID 24065739 DOI: 10.1101/Gad.224899.113 |
0.438 |
|
| 2013 |
Kaur H, Mao S, Shah S, Gorski DH, Krawetz SA, Sloane BF, Mattingly RR. Next-generation sequencing: a powerful tool for the discovery of molecular markers in breast ductal carcinoma in situ. Expert Review of Molecular Diagnostics. 13: 151-65. PMID 23477556 DOI: 10.1586/Erm.13.4 |
0.328 |
|
| 2013 |
Estrella V, Chen T, Lloyd M, Wojtkowiak J, Cornnell HH, Ibrahim-Hashim A, Bailey K, Balagurunathan Y, Rothberg JM, Sloane BF, Johnson J, Gatenby RA, Gillies RJ. Acidity generated by the tumor microenvironment drives local invasion. Cancer Research. 73: 1524-35. PMID 23288510 DOI: 10.1158/0008-5472.Can-12-2796 |
0.675 |
|
| 2013 |
Strand DW, DeGraff DJ, Jiang M, Sameni M, Franco OE, Love HD, Hayward WJ, Lin-Tsai O, Wang AY, Cates JM, Sloane BF, Matusik RJ, Hayward SW. Deficiency in metabolic regulators PPARγ and PTEN cooperates to drive keratinizing squamous metaplasia in novel models of human tissue regeneration. The American Journal of Pathology. 182: 449-59. PMID 23219716 DOI: 10.1016/J.Ajpath.2012.10.007 |
0.364 |
|
| 2013 |
Caglič D, Repnik U, Jedeszko C, Kosec G, Miniejew C, Kindermann M, Vasiljeva O, Turk V, Wendt KU, Sloane BF, Goldring MB, Turk B. The proinflammatory cytokines interleukin-1α and tumor necrosis factor α promote the expression and secretion of proteolytically active cathepsin S from human chondrocytes. Biological Chemistry. 394: 307-16. PMID 23152404 DOI: 10.1515/Hsz-2012-0283 |
0.761 |
|
| 2013 |
Reichenbach G, Starzinski-Powitz A, Sloane BF, Doll M, Kippenberger S, Bernd A, Kaufmann R, Meissner M. PPARα agonist Wy14643 suppresses cathepsin B in human endothelial cells via transcriptional, post-transcriptional and post-translational mechanisms. Angiogenesis. 16: 223-33. PMID 23096928 DOI: 10.1007/S10456-012-9314-9 |
0.385 |
|
| 2013 |
Mohamed MM, El-Ghonaimy EA, Nouh MA, Schneider RJ, Sloane BF, El-Shinawi M. Abstract B40: Cytokines secreted by macrophages isolated from tumor microenvironment of inflammatory breast cancer patients possess chemotactic properties Cancer Research. 73. DOI: 10.1158/1538-7445.Fbcr13-B40 |
0.402 |
|
| 2012 |
Mullins SR, Sameni M, Blum G, Bogyo M, Sloane BF, Moin K. Three-dimensional cultures modeling premalignant progression of human breast epithelial cells: role of cysteine cathepsins. Biological Chemistry. 393: 1405-16. PMID 23667900 DOI: 10.1515/Hsz-2012-0252 |
0.773 |
|
| 2012 |
Kaur H, Mao S, Li Q, Sameni M, Krawetz SA, Sloane BF, Mattingly RR. RNA-Seq of human breast ductal carcinoma in situ models reveals aldehyde dehydrogenase isoform 5A1 as a novel potential target. Plos One. 7: e50249. PMID 23236365 DOI: 10.1371/Journal.Pone.0050249 |
0.397 |
|
| 2012 |
Wojtkowiak JW, Rothberg JM, Kumar V, Schramm KJ, Haller E, Proemsey JB, Lloyd MC, Sloane BF, Gillies RJ. Chronic autophagy is a cellular adaptation to tumor acidic pH microenvironments. Cancer Research. 72: 3938-47. PMID 22719070 DOI: 10.1158/0008-5472.Can-11-3881 |
0.678 |
|
| 2012 |
Sloane BF. On how mammary gland reprogramming metalloproteinases couple form with function. Cold Spring Harbor Perspectives in Biology. 4: a013474. PMID 22661591 DOI: 10.1101/Cshperspect.A013474 |
0.401 |
|
| 2012 |
Sameni M, Anbalagan A, Olive MB, Moin K, Mattingly RR, Sloane BF. MAME models for 4D live-cell imaging of tumor: microenvironment interactions that impact malignant progression Journal of Visualized Experiments : Jove. PMID 22371028 DOI: 10.3791/3661 |
0.48 |
|
| 2012 |
Moin K, Sameni M, Victor BC, Rothberg JM, Mattingly RR, Sloane BF. 3D/4D functional imaging of tumor-associated proteolysis: impact of microenvironment. Methods in Enzymology. 506: 175-94. PMID 22341225 DOI: 10.1016/B978-0-12-391856-7.00034-2 |
0.802 |
|
| 2012 |
Al Sorkhy M, Ferraiuolo RM, Jalili E, Malysa A, Fratiloiu AR, Sloane BF, Porter LA. The cyclin-like protein Spy1/RINGO promotes mammary transformation and is elevated in human breast cancer. Bmc Cancer. 12: 45. PMID 22280365 DOI: 10.1186/1471-2407-12-45 |
0.398 |
|
| 2012 |
Withana NP, Blum G, Sameni M, Slaney C, Anbalagan A, Olive MB, Bidwell BN, Edgington L, Wang L, Moin K, Sloane BF, Anderson RL, Bogyo MS, Parker BS. Cathepsin B inhibition limits bone metastasis in breast cancer. Cancer Research. 72: 1199-209. PMID 22266111 DOI: 10.1158/0008-5472.Can-11-2759 |
0.424 |
|
| 2012 |
Rothberg JM, Sameni M, Moin K, Sloane BF. Live-cell imaging of tumor proteolysis: impact of cellular and non-cellular microenvironment. Biochimica Et Biophysica Acta. 1824: 123-32. PMID 21854877 DOI: 10.1016/J.Bbapap.2011.07.025 |
0.731 |
|
| 2012 |
Rothberg JM, Bogyo MS, Sloane BF. Abstract 2467: Acidic pericellular pH increases contribution of cathepsin B to invasiveness of a human breast carcinoma cell line Cancer Research. 72: 2467-2467. DOI: 10.1158/1538-7445.Am2012-2467 |
0.737 |
|
| 2012 |
ElGhonaimy E, El-Shinawi M, Abd-El-Tawab R, Mamlouk TE, Sloane B, Mohamed M. Abstract P1-05-11: Biological characterization of tumor-associated leukocytes in positive and negative lymph node breast cancer patients Cancer Research. 72. DOI: 10.1158/0008-5472.Sabcs12-P1-05-11 |
0.337 |
|
| 2012 |
Zhao C, Radulovic M, Jecmenica M, Patel S, Korsten MA, Sloane BF. Su1841 Interaction of DP1 and Cathepsin B in Colon Cancer Gastroenterology. 142: S-516-S-517. DOI: 10.1016/S0016-5085(12)61981-7 |
0.319 |
|
| 2012 |
Sameni M, Mullins SR, Moin K, Sloane BF, Osuala K. Modeling breast cancer progression in 4-D Breast Cancer Metastasis and Drug Resistance: Progress and Prospects. 177-188. DOI: 10.1007/978-1-4614-5647-6_10 |
0.734 |
|
| 2011 |
Victor BC, Anbalagan A, Mohamed MM, Sloane BF, Cavallo-Medved D. Inhibition of cathepsin B activity attenuates extracellular matrix degradation and inflammatory breast cancer invasion. Breast Cancer Research : Bcr. 13: R115. PMID 22093547 DOI: 10.1186/Bcr3058 |
0.75 |
|
| 2011 |
Wojtkowiak JW, Sane KM, Kleinman M, Sloane BF, Reiners JJ, Mattingly RR. Aborted autophagy and nonapoptotic death induced by farnesyl transferase inhibitor and lovastatin. The Journal of Pharmacology and Experimental Therapeutics. 337: 65-74. PMID 21228063 DOI: 10.1124/Jpet.110.174573 |
0.358 |
|
| 2011 |
Nouh MA, Mohamed MM, El-Shinawi M, Shaalan MA, Cavallo-Medved D, Khaled HM, Sloane BF. Cathepsin B: a potential prognostic marker for inflammatory breast cancer. Journal of Translational Medicine. 9: 1. PMID 21199580 DOI: 10.1186/1479-5876-9-1 |
0.36 |
|
| 2011 |
Sloane B, Sameni M, Anbalagan A, Olive M, Shokoohi N, Moin K, Mattingly R. 4D MAME Models for Live-Cell Imaging of Interactions Between Breast Tumor Cells and Their Microenvironment Microscopy and Microanalysis. 17: 62-63. DOI: 10.1017/S1431927611001188 |
0.445 |
|
| 2010 |
El-Shinawi M, Abdelwahab SF, Sobhy M, Nouh MA, Sloane BF, Mohamed MM. Capturing and characterizing immune cells from breast tumor microenvironment: an innovative surgical approach. Annals of Surgical Oncology. 17: 2677-84. PMID 20333554 DOI: 10.1245/S10434-010-1029-9 |
0.419 |
|
| 2010 |
Mohamed MM, Cavallo-Medved D, Rudy D, Anbalagan A, Moin K, Sloane BF. Interleukin-6 increases expression and secretion of cathepsin B by breast tumor-associated monocytes. Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology. 25: 315-24. PMID 20110692 DOI: 10.1159/000276564 |
0.447 |
|
| 2010 |
Trivedi ER, Harney AS, Olive MB, Podgorski I, Moin K, Sloane BF, Barrett AG, Meade TJ, Hoffman BM. Chiral porphyrazine near-IR optical imaging agent exhibiting preferential tumor accumulation. Proceedings of the National Academy of Sciences of the United States of America. 107: 1284-8. PMID 20080563 DOI: 10.1073/Pnas.0912811107 |
0.443 |
|
| 2010 |
Sameni M, Anbalagan A, Sloane BF. Abstract 2253: Proteases and cytokines in the transition from preinvasive DCIS to invasive breast carcinoma Cancer Research. 70: 2253-2253. DOI: 10.1158/1538-7445.Am10-2253 |
0.313 |
|
| 2009 |
Jedeszko C, Victor BC, Podgorski I, Sloane BF. Fibroblast hepatocyte growth factor promotes invasion of human mammary ductal carcinoma in situ. Cancer Research. 69: 9148-55. PMID 19920187 DOI: 10.1158/0008-5472.Can-09-1043 |
0.795 |
|
| 2009 |
Podgorski I, Linebaugh BE, Koblinski JE, Rudy DL, Herroon MK, Olive MB, Sloane BF. Bone marrow-derived cathepsin K cleaves SPARC in bone metastasis American Journal of Pathology. 175: 1255-1269. PMID 19700761 DOI: 10.2353/Ajpath.2009.080906 |
0.318 |
|
| 2009 |
Moin K, Schwartz D, Mullins SR, Sloane BF. Microarrays for protease detection in tissues and cells. Methods in Molecular Biology (Clifton, N.J.). 539: 49-57. PMID 19377971 DOI: 10.1007/978-1-60327-003-8_3 |
0.762 |
|
| 2009 |
Cavallo-Medved D, Rudy D, Blum G, Bogyo M, Caglic D, Sloane BF. Live-cell imaging demonstrates extracellular matrix degradation in association with active cathepsin B in caveolae of endothelial cells during tube formation. Experimental Cell Research. 315: 1234-46. PMID 19331819 DOI: 10.1016/J.Yexcr.2009.01.021 |
0.448 |
|
| 2009 |
Robey IF, Baggett BK, Kirkpatrick ND, Roe DJ, Dosescu J, Sloane BF, Hashim AI, Morse DL, Raghunand N, Gatenby RA, Gillies RJ. Bicarbonate increases tumor pH and inhibits spontaneous metastases. Cancer Research. 69: 2260-8. PMID 19276390 DOI: 10.1158/0008-5472.Can-07-5575 |
0.459 |
|
| 2009 |
Devetzi M, Scorilas A, Tsiambas E, Sameni M, Fotiou S, Sloane BF, Talieri M. Cathepsin B protein levels in endometrial cancer: Potential value as a tumour biomarker. Gynecologic Oncology. 112: 531-6. PMID 19110306 DOI: 10.1016/J.Ygyno.2008.10.030 |
0.343 |
|
| 2009 |
Sameni M, Cavallo-Medved D, Dosescu J, Jedeszko C, Moin K, Mullins SR, Olive MB, Rudy D, Sloane BF. Imaging and quantifying the dynamics of tumor-associated proteolysis Clinical and Experimental Metastasis. 26: 299-309. PMID 19082919 DOI: 10.1007/S10585-008-9218-7 |
0.807 |
|
| 2009 |
Mohamed M, El-Shinawi M, Cavallo-Medved D, Sobhy M, Nouh M, Abdelwahab S, Sloane B. Monocytes/macrophages and natural killer cells characterize the tumor microenvironment of inflammatory breast cancer in Egyptian patients. Cancer Research. 69: 1054. DOI: 10.1158/0008-5472.Sabcs-1054 |
0.35 |
|
| 2009 |
Tu C, Ortega-Cava CF, Chen G, Fernandes ND, Cavallo-Medved D, Sloane BF, Band V, Band H. Lysosomal cathepsin B participates in the podosome-mediated extracellular matrix degradation and invasion via secreted lysosomes in v-Src fibroblasts (Cancer Research (2008) 68, (9147-9156)) Cancer Research. 69: 381. DOI: 10.1158/0008-5472.Can-69-1-Cor2 |
0.376 |
|
| 2008 |
Sameni M, Dosescu J, Yamada KM, Sloane BF, Cavallo-Medved D. Functional live-cell imaging demonstrates that beta1-integrin promotes type IV collagen degradation by breast and prostate cancer cells. Molecular Imaging. 7: 199-213. PMID 19123990 |
0.341 |
|
| 2008 |
Tu C, Ortega-Cava CF, Chen G, Fernandes ND, Cavallo-Medved D, Sloane BF, Band V, Band H. Lysosomal cathepsin B participates in the podosome-mediated extracellular matrix degradation and invasion via secreted lysosomes in v-Src fibroblasts. Cancer Research. 68: 9147-56. PMID 19010886 DOI: 10.1158/0008-5472.Can-07-5127 |
0.426 |
|
| 2008 |
Mohamed MM, Cavallo-Medved D, Sloane BF. Human monocytes augment invasiveness and proteolytic activity of inflammatory breast cancer. Biological Chemistry. 389: 1117-21. PMID 18710343 DOI: 10.1515/Bc.2008.117 |
0.46 |
|
| 2008 |
Jedeszko C, Sameni M, Olive MB, Moin K, Sloane BF. Visualizing protease activity in living cells: from two dimensions to four dimensions. Current Protocols in Cell Biology / Editorial Board, Juan S. Bonifacino ... [Et Al.]. Unit 4.20. PMID 18551423 DOI: 10.1002/0471143030.Cb0420S39 |
0.778 |
|
| 2008 |
Li Q, Mullins SR, Sloane BF, Mattingly RR. p21-Activated kinase 1 coordinates aberrant cell survival and pericellular proteolysis in a three-dimensional culture model for premalignant progression of human breast cancer. Neoplasia (New York, N.Y.). 10: 314-29. PMID 18392133 DOI: 10.1593/Neo.07970 |
0.76 |
|
| 2008 |
Henkhaus RS, Roy UK, Cavallo-Medved D, Sloane BF, Gerner EW, Ignatenko NA. Caveolin-1-mediated expression and secretion of kallikrein 6 in colon cancer cells. Neoplasia (New York, N.Y.). 10: 140-8. PMID 18283336 DOI: 10.1593/Neo.07817 |
0.411 |
|
| 2008 |
Moin K, Sameni M, Jedeszko C, Li Q, Olive MB, Mattingly RR, Sloane BF. Images of cleavage: Tumor proteases in action The Cancer Degradome: Proteases and Cancer Biology. 137-154. DOI: 10.1007/978-0-387-69057-5_8 |
0.381 |
|
| 2008 |
Schwartz DR, Moin K, Weber E, Sloane BF. The Hu/Mu protin chip: A custom dual-species oligonucleotide microarray for profiling degradome gene expression in tumors and their microenvironment The Cancer Degradome: Proteases and Cancer Biology. 37-47. DOI: 10.1007/978-0-387-69057-5_3 |
0.344 |
|
| 2007 |
Victor BC, Sloane BF. Cysteine cathepsin non-inhibitory binding partners: modulating intracellular trafficking and function. Biological Chemistry. 388: 1131-40. PMID 17976005 DOI: 10.1515/Bc.2007.150 |
0.756 |
|
| 2007 |
Reisenauer A, Eickelberg O, Wille A, Heimburg A, Reinhold A, Sloane BF, Welte T, Bühling F. Increased carcinogenic potential of myeloid tumor cells induced by aberrant TGF-β1-signaling and upregulation of cathepsin B Biological Chemistry. 388: 639-650. PMID 17552911 DOI: 10.1515/Bc.2007.072 |
0.411 |
|
| 2007 |
Schwartz DR, Moin K, Yao B, Matrisian LM, Coussens LM, Bugge TH, Fingleton B, Acuff HB, Sinnamon M, Nassar H, Platts AE, Krawetz SA, Linebaugh BE, Sloane BF. Hu/Mu ProtIn oligonucleotide microarray: dual-species array for profiling protease and protease inhibitor gene expression in tumors and their microenvironment. Molecular Cancer Research : McR. 5: 443-54. PMID 17510311 DOI: 10.1158/1541-7786.Mcr-06-0337 |
0.373 |
|
| 2007 |
Calkins CC, Dosescu J, Day NA, Ren WP, Fridman R, Sloane BF, Moin K. Functional expression of recombinant human stefin A in mammalian and bacterial cells. Protein Expression and Purification. 52: 463-71. PMID 17208452 DOI: 10.1016/J.Pep.2006.11.020 |
0.35 |
|
| 2006 |
Sloane BF, Gillies RJ, Mohla S, Sogn JA, Menkens AE, Sullivan DC. I2 imaging: cancer biology and the tumor microenvironment. Cancer Research. 66: 11097-9. PMID 17114235 DOI: 10.1158/Aacr.Edb-Can-06-3102 |
0.412 |
|
| 2006 |
Mohamed MM, Sloane BF. Cysteine cathepsins: multifunctional enzymes in cancer. Nature Reviews. Cancer. 6: 764-75. PMID 16990854 DOI: 10.1038/Nrc1949 |
0.438 |
|
| 2006 |
Acuff HB, Sinnamon M, Fingleton B, Boone B, Levy SE, Chen X, Pozzi A, Carbone DP, Schwartz DR, Moin K, Sloane BF, Matrisian LM. Analysis of host- and tumor-derived proteinases using a custom dual species microarray reveals a protective role for stromal matrix metalloproteinase-12 in non-small cell lung cancer. Cancer Research. 66: 7968-75. PMID 16912171 DOI: 10.1158/0008-5472.Can-05-4279 |
0.396 |
|
| 2006 |
Podgorski I, Sloane BF. Loss of caspase-8 in tumor cells: mechanism to overcome integrin-mediated death? Molecular Interventions. 6: 132-6. PMID 16809473 DOI: 10.1124/Mi.6.3.3 |
0.381 |
|
| 2006 |
Caserman S, Kenig S, Sloane BF, Lah TT. Cathepsin L splice variants in human breast cell lines. Biological Chemistry. 387: 629-34. PMID 16740135 DOI: 10.1515/Bc.2006.080 |
0.316 |
|
| 2006 |
Jane DT, Morvay L, Dasilva L, Cavallo-Medved D, Sloane BF, Dufresne MJ. Cathepsin B localizes to plasma membrane caveolae of differentiating myoblasts and is secreted in an active form at physiological pH. Biological Chemistry. 387: 223-34. PMID 16497156 DOI: 10.1515/Bc.2006.030 |
0.374 |
|
| 2006 |
Sloane BF, Sameni M, Podgorski I, Cavallo-Medved D, Moin K. Functional imaging of tumor proteolysis. Annual Review of Pharmacology and Toxicology. 46: 301-15. PMID 16402907 DOI: 10.1146/Annurev.Pharmtox.45.120403.095853 |
0.501 |
|
| 2006 |
Démoz M, Castino R, Follo C, Hasilik A, Sloane BF, Isidoro C. High yield synthesis and characterization of phosphorylated recombinant human procathepsin D expressed in mammalian cells. Protein Expression and Purification. 45: 157-67. PMID 16242956 DOI: 10.1016/J.Pep.2005.07.024 |
0.367 |
|
| 2005 |
Blum G, Mullins SR, Keren K, Fonovic M, Jedeszko C, Rice MJ, Sloane BF, Bogyo M. Dynamic imaging of protease activity with fluorescently quenched activity-based probes. Nature Chemical Biology. 1: 203-9. PMID 16408036 DOI: 10.1038/Nchembio728 |
0.771 |
|
| 2005 |
Podgorski I, Linebaugh BE, Sameni M, Jedeszko C, Bhagat S, Cher ML, Sloane BF. Bone microenvironment modulates expression and activity of cathepsin B in prostate cancer. Neoplasia (New York, N.Y.). 7: 207-23. PMID 15799821 DOI: 10.1593/Neo.04349 |
0.782 |
|
| 2005 |
Dong Z, Bonfil RD, Chinni S, Deng X, Trindade Filho JC, Bernardo M, Vaishampayan U, Che M, Sloane BF, Sheng S, Fridman R, Cher ML. Matrix metalloproteinase activity and osteoclasts in experimental prostate cancer bone metastasis tissue. The American Journal of Pathology. 166: 1173-86. PMID 15793297 DOI: 10.1016/S0002-9440(10)62337-1 |
0.375 |
|
| 2005 |
Cavallo-Medved D, Mai J, Dosescu J, Sameni M, Sloane BF. Caveolin-1 mediates the expression and localization of cathepsin B, pro-urokinase plasminogen activator and their cell-surface receptors in human colorectal carcinoma cells. Journal of Cell Science. 118: 1493-503. PMID 15769846 DOI: 10.1242/Jcs.02278 |
0.469 |
|
| 2005 |
Sloane BF, Yan S, Podgorski I, Linebaugh BE, Cher ML, Mai J, Cavallo-Medved D, Sameni M, Dosescu J, Moin K. Cathepsin B and tumor proteolysis: contribution of the tumor microenvironment. Seminars in Cancer Biology. 15: 149-57. PMID 15652460 DOI: 10.1016/J.Semcancer.2004.08.001 |
0.458 |
|
| 2004 |
Jedeszko C, Sloane BF. Cysteine cathepsins in human cancer. Biological Chemistry. 385: 1017-27. PMID 15576321 DOI: 10.1515/Bc.2004.132 |
0.798 |
|
| 2004 |
Zhang J, Shridhar R, Dai Q, Song J, Barlow SC, Yin L, Sloane BF, Miller FR, Meschonat C, Li BD, Abreo F, Keppler D. Cystatin m: a novel candidate tumor suppressor gene for breast cancer. Cancer Research. 64: 6957-64. PMID 15466187 DOI: 10.1158/0008-5472.Can-04-0819 |
0.639 |
|
| 2004 |
Yan S, Sloane BF. Isolation of a novel USF2 isoform: repressor of cathepsin B expression. Gene. 337: 199-206. PMID 15276216 DOI: 10.1016/J.Gene.2004.05.005 |
0.387 |
|
| 2004 |
Caruso JA, Mathieu PA, Joiakim A, Leeson B, Kessel D, Sloane BF, Reiners JJ. Differential susceptibilities of murine hepatoma 1c1c7 and Tao cells to the lysosomal photosensitizer NPe6: influence of aryl hydrocarbon receptor on lysosomal fragility and protease contents. Molecular Pharmacology. 65: 1016-28. PMID 15044632 DOI: 10.1124/Mol.65.4.1016 |
0.411 |
|
| 2004 |
DeClerck YA, Mercurio AM, Stack MS, Chapman HA, Zutter MM, Muschel RJ, Raz A, Matrisian LM, Sloane BF, Noel A, Hendrix MJ, Coussens L, Padarathsingh M. Proteases, extracellular matrix, and cancer: a workshop of the path B study section. The American Journal of Pathology. 164: 1131-9. PMID 15039201 DOI: 10.1016/S0002-9440(10)63200-2 |
0.499 |
|
| 2004 |
Shridhar R, Zhang J, Song J, Booth BA, Kevil CG, Sotiropoulou G, Sloane BF, Keppler D. Cystatin M suppresses the malignant phenotype of human MDA-MB-435S cells. Oncogene. 23: 2206-15. PMID 14676833 DOI: 10.1038/Sj.Onc.1207340 |
0.664 |
|
| 2003 |
Cavallo-Medved D, Dosescu J, Linebaugh BE, Sameni M, Rudy D, Sloane BF. Mutant K-ras regulates cathepsin B localization on the surface of human colorectal carcinoma cells. Neoplasia (New York, N.Y.). 5: 507-19. PMID 14965444 DOI: 10.1016/S1476-5586(03)80035-0 |
0.419 |
|
| 2003 |
Yan S, Jane DT, Dufresne MJ, Sloane BF. Transcription of cathepsin B in glioma cells: regulation by an E-box adjacent to the transcription initiation site. Biological Chemistry. 384: 1421-7. PMID 14669984 DOI: 10.1515/Bc.2003.157 |
0.365 |
|
| 2003 |
Sameni M, Dosescu J, Moin K, Sloane BF. Functional imaging of proteolysis: stromal and inflammatory cells increase tumor proteolysis. Molecular Imaging. 2: 159-75. PMID 14649059 DOI: 10.1162/153535003322556903 |
0.502 |
|
| 2003 |
Podgorski I, Sloane BF. Cathepsin B and its role(s) in cancer progression. Biochemical Society Symposium. 263-76. PMID 14587299 DOI: 10.1042/Bss0700263 |
0.425 |
|
| 2003 |
Yan S, Sloane BF. Molecular regulation of human cathepsin B: implication in pathologies. Biological Chemistry. 384: 845-54. PMID 12887051 DOI: 10.1515/Bc.2003.095 |
0.422 |
|
| 2003 |
Roshy S, Sloane BF, Moin K. Pericellular cathepsin B and malignant progression. Cancer Metastasis Reviews. 22: 271-86. PMID 12785001 DOI: 10.1023/A:1023007717757 |
0.472 |
|
| 2003 |
Bervar A, Zajc I, Sever N, Katunuma N, Sloane BF, Lah TT. Invasiveness of transformed human breast epithelial cell lines is related to cathepsin B and inhibited by cysteine proteinase inhibitors. Biological Chemistry. 384: 447-55. PMID 12715895 DOI: 10.1515/Bc.2003.050 |
0.5 |
|
| 2003 |
Cavallo-Medved D, Sloane BF. Cell-surface cathepsin B: understanding its functional significance. Current Topics in Developmental Biology. 54: 313-41. PMID 12696754 DOI: 10.1016/S0070-2153(03)54013-3 |
0.474 |
|
| 2002 |
Jane DT, Morvay LC, Koblinski J, Yan S, Saad FA, Sloane BF, Dufresne MJ. Evidence that E-box promoter elements and MyoD transcription factors play a role in the induction of cathepsin B gene expression during human myoblast differentiation. Biological Chemistry. 383: 1833-44. PMID 12553720 DOI: 10.1515/Bc.2002.207 |
0.372 |
|
| 2002 |
Mai J, Sameni M, Mikkelsen T, Sloane BF. Degradation of extracellular matrix protein tenascin-C by cathepsin B: an interaction involved in the progression of gliomas. Biological Chemistry. 383: 1407-13. PMID 12437133 DOI: 10.1515/Bc.2002.159 |
0.459 |
|
| 2002 |
Scorilas A, Fotiou S, Tsiambas E, Yotis J, Kotsiandri F, Sameni M, Sloane BF, Talieri M. Determination of cathepsin B expression may offer additional prognostic information for ovarian cancer patients. Biological Chemistry. 383: 1297-303. PMID 12437120 DOI: 10.1515/Bc.2002.146 |
0.374 |
|
| 2002 |
Jane DT, Morvay LC, Allen F, Sloane BF, Dufresne MJ. Selective inhibition of cathepsin B with cell-permeable CA074Me negatively affects L6 rat myoblast differentiation. Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire. 80: 457-65. PMID 12234099 DOI: 10.1139/O02-134 |
0.39 |
|
| 2002 |
Koblinski JE, Dosescu J, Sameni M, Moin K, Clark K, Sloane BF. Interaction of human breast fibroblasts with collagen I increases secretion of procathepsin B. The Journal of Biological Chemistry. 277: 32220-7. PMID 12072442 DOI: 10.1074/Jbc.M204708200 |
0.468 |
|
| 2002 |
Marten K, Bremer C, Khazaie K, Sameni M, Sloane B, Tung C, Weissleder R. Detection of dysplastic intestinal adenomas using enzyme-sensing molecular beacons in mice Gastroenterology. 122: 406-414. PMID 11832455 DOI: 10.1053/Gast.2002.30990 |
0.356 |
|
| 2002 |
Guo M, Mathieu PA, Linebaugh B, Sloane BF, Reiners JJ. Phorbol ester activation of a proteolytic cascade capable of activating latent transforming growth factor-betaL a process initiated by the exocytosis of cathepsin B. The Journal of Biological Chemistry. 277: 14829-37. PMID 11815600 DOI: 10.1074/Jbc.M108180200 |
0.392 |
|
| 2002 |
Jane DT, DaSilva L, Koblinski J, Horwitz M, Sloane BF, Dufresne MJ. Evidence for the involvement of cathepsin B in skeletal myoblast differentiation. Journal of Cellular Biochemistry. 84: 520-31. PMID 11813257 DOI: 10.1002/Jcb.10042 |
0.364 |
|
| 2002 |
Waghray A, Keppler D, Sloane BF, Schuger L, Chen YQ. Analysis of a truncated form of cathepsin H in human prostate tumor cells. The Journal of Biological Chemistry. 277: 11533-8. PMID 11796715 DOI: 10.1074/Jbc.M109557200 |
0.361 |
|
| 2001 |
Sinha AA, Jamuar MP, Wilson MJ, Rozhin J, Sloane BF. Plasma membrane association of cathepsin B in human prostate cancer: Biochemical and immunogold electron microscopic analysis Prostate. 49: 172-184. PMID 11746262 DOI: 10.1002/Pros.1132 |
0.326 |
|
| 2001 |
Dong Z, Katar M, Linebaugh BE, Sloane BF, Berk RS. Expression of cathepsins B, D and L in mouse corneas infected with Pseudomonas aeruginosa European Journal of Biochemistry. 268: 6408-6416. PMID 11737195 DOI: 10.1046/J.0014-2956.2001.02607.X |
0.329 |
|
| 2001 |
Sinha AA, Quast BJ, Wilson MJ, Fernandes ET, Reddy PK, Ewing SL, Sloane BF, Gleason DF. Ratio of cathepsin B to stefin A identifies heterogeneity within Gleason histologic scores for human prostate cancer. The Prostate. 48: 274-84. PMID 11536307 DOI: 10.1002/Pros.1107 |
0.358 |
|
| 2001 |
Premzl A, Puizdar V, Zavašnik-Bergant V, Kopitar-Jerala N, Lah TT, Katunuma N, Sloane BF, Turk V, Kos J. Invasion of ras-transformed breast epithelial cells depends on the proteolytic activity of cysteine and aspartic proteinases Biological Chemistry. 382: 853-857. PMID 11517941 DOI: 10.1515/Bc.2001.104 |
0.439 |
|
| 2001 |
Sameni M, Dosescu J, Sloane BF. Imaging proteolysis by living human glioma cells Biological Chemistry. 382: 785-788. PMID 11517931 DOI: 10.1515/Bc.2001.094 |
0.457 |
|
| 2001 |
Fernández PL, Farré X, Nadal A, Fernández E, Peiró N, Sloane BF, Shi GP, Chapman HA, Campo E, Cardesa A. Expression of cathepsins B and S in the progression of prostate carcinoma. International Journal of Cancer. Journal International Du Cancer. 95: 51-5. PMID 11241311 DOI: 10.1002/1097-0215(20010120)95:1<51::Aid-Ijc1009>3.0.Co;2-J |
0.378 |
|
| 2001 |
Chen X, Ren W, Dong J, Xiao S, Sloane BF. Screening of gastric cancer cell sublines using the adhesion method Chinese Journal of Digestive Diseases. 2: 121-124. DOI: 10.1046/J.1443-9573.2001.00041.X |
0.447 |
|
| 2000 |
Sameni M, Moin K, Sloane BF. Imaging proteolysis by living human breast cancer cells Neoplasia. 2: 496-504. PMID 11228542 DOI: 10.1038/Sj.Neo.7900116 |
0.439 |
|
| 2000 |
Ahram M, Sameni M, Qiu RG, Linebaugh B, Kirn D, Sloane BF. Rac1-induced endocytosis is associated with intracellular proteolysis during migration through a three-dimensional matrix Experimental Cell Research. 260: 292-303. PMID 11035924 DOI: 10.1006/Excr.2000.5031 |
0.405 |
|
| 2000 |
Hulkower KI, Butler CC, Linebaugh BE, Klaus JL, Keppler D, Giranda VL, Sloane BF. Fluorescent microplate assay for cancer cell-associated cathepsin b European Journal of Biochemistry. 267: 4165-4170. PMID 10866820 DOI: 10.1046/J.1432-1327.2000.01458.X |
0.459 |
|
| 2000 |
Moin K, Demchik L, Mai J, Duessing J, Peters C, Sloane BF. Observing proteases in living cells Advances in Experimental Medicine and Biology. 477: 391-401. PMID 10849765 DOI: 10.1007/0-306-46826-3_40 |
0.798 |
|
| 2000 |
Mai J, Finley RL, Waisman DM, Sloane BF. Human procathepsin B interacts with the annexin II tetramer on the surface of tumor cells Journal of Biological Chemistry. 275: 12806-12812. PMID 10777578 DOI: 10.1074/Jbc.275.17.12806 |
0.444 |
|
| 2000 |
Mai J, Waisman DM, Sloane BF. Cell surface complex of cathepsin B/annexin II tetramer in malignant progression Biochimica Et Biophysica Acta - Protein Structure and Molecular Enzymology. 1477: 215-230. PMID 10708859 DOI: 10.1016/S0167-4838(99)00274-5 |
0.498 |
|
| 2000 |
Yan S, Berquin IM, Troen BR, Sloane BF. Transcription of human cathepsin B is mediated by Sp1 and Ets family factors in glioma Dna and Cell Biology. 19: 79-91. PMID 10701774 DOI: 10.1089/104454900314591 |
0.33 |
|
| 2000 |
Koblinski JE, Ahram M, Sloane BF. Unraveling the role of proteases in cancer Clinica Chimica Acta. 291: 113-135. PMID 10675719 DOI: 10.1016/S0009-8981(99)00224-7 |
0.513 |
|
| 2000 |
Shridhar R, Sloane BF, Keppler D. Inhibitors of Papain-Like Cysteine Peptidases in Cancer Handbook of Experimental Pharmacology. 140: 301-328. DOI: 10.1007/978-3-642-57092-6_16 |
0.587 |
|
| 1999 |
Demchik LL, Sameni M, Nelson K, Mikkelsen T, Sloane BF. Cathepsin B and glioma invasion. International Journal of Developmental Neuroscience : the Official Journal of the International Society For Developmental Neuroscience. 17: 483-94. PMID 10571410 DOI: 10.1016/S0736-5748(99)00011-8 |
0.809 |
|
| 1999 |
Linebaugh BE, Sameni M, Day NA, Sloane BF, Keppler D. Exocytosis of active cathepsin B enzyme activity at pH 7.0, inhibition and molecular mass. European Journal of Biochemistry / Febs. 264: 100-9. PMID 10447678 DOI: 10.1046/J.1432-1327.1999.00582.X |
0.418 |
|
| 1999 |
Frosch BA, Berquin I, Emmert-Buck MR, Moin K, Sloane BF. Molecular regulation, membrane association and secretion of tumor cathepsin B. Apmis : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica. 107: 28-37. PMID 10190277 DOI: 10.1111/J.1699-0463.1999.Tb01523.X |
0.447 |
|
| 1998 |
Bjarnadottir M, Wulff BS, Sameni M, Sloane BF, Keppler D, Grubb A, Abrahamson M. Intracellular accumulation of the amyloidogenic L68Q variant of human cystatin C in NIH/3T3 cells Journal of Clinical Pathology - Molecular Pathology. 51: 317-326. PMID 10193512 DOI: 10.1136/Mp.51.6.317 |
0.325 |
|
| 1998 |
Nishimura Y, Sameni M, Sloane BF. Malignant transformation alters intracellular trafficking of lysosomal cathepsin D in human breast epithelial cells Pathology and Oncology Research. 4: 283-296. PMID 9887359 DOI: 10.1007/Bf02905219 |
0.415 |
|
| 1998 |
Moin K, Cao L, Day NA, Koblinski JE, Sloane BF. Tumor cell membrane cathepsin B. Biological Chemistry. 379: 1093-9. PMID 9792442 DOI: 10.1515/Bchm.1998.379.8-9.1093 |
0.439 |
|
| 1998 |
Sinha AA, Quast BJ, Wilson MJ, Reddy PK, Gleason DF, Sloane BF. Codistribution of procathepsin B and mature cathepsin B forms in human prostate tumors detected by confocal and immunofluorescence microscopy. The Anatomical Record. 252: 281-9. PMID 9776083 DOI: 10.1002/(Sici)1097-0185(199810)252:2<281::Aid-Ar14>3.0.Co;2-J |
0.37 |
|
| 1998 |
Calkins CC, Sameni M, Koblinski J, Sloane BF, Moin K. Differential localization of cysteine protease inhibitors and a target cysteine protease, cathepsin B, by immuno-confocal microscopy Journal of Histochemistry and Cytochemistry. 46: 745-751. PMID 9603786 DOI: 10.1177/002215549804600607 |
0.456 |
|
| 1998 |
Yan S, Sameni M, Sloane BF. Cathepsin B and human tumor progression Biological Chemistry. 379: 113-123. PMID 9524062 |
0.382 |
|
| 1997 |
Berquin IM, Ahram M, Sloane BF. Exon 2 of human cathepsin B derives from an Alu element Febs Letters. 419: 121-123. PMID 9426233 DOI: 10.1016/S0014-5793(97)01445-2 |
0.322 |
|
| 1997 |
Seyfried D, Han Y, Zheng Z, Day N, Moin K, Rempel S, Sloane B, Chopp M. Cathepsin B and middle cerebral artery occlusion in the rat Journal of Neurosurgery. 87: 716-723. PMID 9347980 DOI: 10.3171/Jns.1997.87.5.0716 |
0.321 |
|
| 1997 |
Sloane BF, Keppler D, Sameni M, Ahram M, Mikkelsen T. Cathepsinb: Regulation of expression and localization at sites of cell/matrk contact Faseb Journal. 11. |
0.435 |
|
| 1996 |
Sloane BF. Suicidal tumor proteases Nature Biotechnology. 14: 826-827. PMID 9631001 DOI: 10.1038/Nbt0796-826B |
0.328 |
|
| 1996 |
Keppler D, Sameni M, Moin K, Mikkelsen T, Diglio CA, Sloane BF. Tumor progression and angiogenesis: Cathepsin B & Co Biochemistry and Cell Biology. 74: 799-810. PMID 9164649 DOI: 10.1139/O96-086 |
0.501 |
|
| 1996 |
Ren WP, Fridman R, Zabrecky JR, Morris LD, Day NA, Sloane BF. Expression of functional recombinant human procathepsin B in mammalian cells. The Biochemical Journal. 319: 793-800. PMID 8920982 DOI: 10.1042/Bj3190793 |
0.423 |
|
| 1996 |
Berquin IM, Sloane BF. Cathepsin B expression in human tumors Advances in Experimental Medicine and Biology. 389: 281-294. PMID 8861022 DOI: 10.1007/978-1-4613-0335-0_35 |
0.481 |
|
| 1996 |
Keppler D, Sloane BF. Cathepsin B: Multiple enzyme forms from a single gene and their relation to cancer Enzyme and Protein. 49: 94-105. PMID 8797000 |
0.318 |
|
| 1996 |
Elliott E, Sloane BF. The cysteine protease cathepsin B in cancer Perspectives in Drug Discovery and Design. 6: 12-32. DOI: 10.1007/Bf02174043 |
0.467 |
|
| 1995 |
Sameni M, Elliott E, Ziegler G, Fortgens PH, Dennison C, Sloane BF. Cathepsin B and D are Localized at the Surface of Human Breast Cancer Cells. Pathology Oncology Research : Por. 1: 43-53. PMID 11173567 DOI: 10.1007/Bf02893583 |
0.467 |
|
| 1995 |
Sinha AA, Wilson MJ, Gleason DF, Reddy PK, Sameni M, Sloane BF. Immunohistochemical localization of cathepsin B in neoplastic human prostate. The Prostate. 26: 171-8. PMID 7716081 DOI: 10.1002/Pros.2990260402 |
0.419 |
|
| 1995 |
Berquin IM, Cao L, Fong D, Sloane BF. Identification of two new exons and multiple transcription start points in the 5′-untranslated region of the human cathepsin-B-encoding gene Gene. 159: 143-149. PMID 7622042 DOI: 10.1016/0378-1119(95)00072-E |
0.327 |
|
| 1995 |
Mikkelsen T, Yan PS, Ho KL, Sameni M, Sloane BF, Rosenblum ML. Immunolocalization of cathepsin B in human glioma: implications for tumor invasion and angiogenesis. Journal of Neurosurgery. 83: 285-90. PMID 7542317 DOI: 10.3171/Jns.1995.83.2.0285 |
0.459 |
|
| 1995 |
Sinha AA, Gleason DF, Staley NA, Wilson MJ, Sameni M, Sloane BF. Cathepsin B in angiogenesis of human prostate: an immunohistochemical and immunoelectron microscopic analysis. The Anatomical Record. 241: 353-62. PMID 7538734 DOI: 10.1002/Ar.1092410309 |
0.331 |
|
| 1995 |
Berquin IM, Sloane BF. Cysteine proteases and tumor progression Perspectives in Drug Discovery and Design. 2: 371-388. DOI: 10.1007/Bf02172031 |
0.469 |
|
| 1994 |
Sloane BF, Moin K, Sameni M, Tait LR, Rozhin J, Ziegler G. Membrane association of cathepsin B can be induced by transfection of human breast epithelial cells with c-Ha-ras oncogene. Journal of Cell Science. 107: 373-84. PMID 8207069 |
0.349 |
|
| 1994 |
Visscher DW, Sloane BF, Sameni M, Babiarz JW, Jacobson J, Crissman JD. Clinicopathologic significance of cathepsin B immunostaining in transitional neoplasia Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 7: 76-81. PMID 8159656 |
0.315 |
|
| 1994 |
Cao L, Taggart RT, Berquin IM, Moin K, Fong D, Sloane BF. Human gastric adenocarcinoma cathepsin B: isolation and sequencing of full-length cDNAs and polymorphisms of the gene Gene. 139: 163-169. PMID 8112600 DOI: 10.1016/0378-1119(94)90750-1 |
0.323 |
|
| 1994 |
Castiglioni T, Merino MJ, Elsner B, Lah TT, Sloane BF, Emmert-Buck MR. Immunohistochemical analysis of cathepsins D, B, and L in human breast cancer. Human Pathology. 25: 857-62. PMID 8088759 DOI: 10.1016/0046-8177(94)90003-5 |
0.459 |
|
| 1994 |
Emmert-Buck MR, Roth MJ, Zhuang Z, Campo E, Rozhin J, Sloane BF, Liotta LA, Stetler-Stevenson WG. Increased gelatinase A (MMP-2) and cathepsin B activity in invasive tumor regions of human colon cancer samples American Journal of Pathology. 145: 1285-1290. PMID 7992833 |
0.387 |
|
| 1994 |
Rozhin J, Sameni M, Ziegler G, Sloane BF. Pericellular pH affects distribution and secretion of cathepsin B in malignant cells. Cancer Research. 54: 6517-25. PMID 7987851 |
0.328 |
|
| 1994 |
Honn KV, Timár J, Rozhin J, Bazaz R, Sameni M, Ziegler G, Sloane BF. A lipoxygenase metabolite, 12-(S)-HETE, stimulates protein kinase C-mediated release of cathepsin B from malignant cells. Experimental Cell Research. 214: 120-30. PMID 7521840 DOI: 10.1006/Excr.1994.1240 |
0.48 |
|
| 1994 |
Campo E, Muñoz J, Miquel R, Palacín A, Cardesa A, Sloane BF, Emmert-Buck MR. Cathepsin B expression in colorectal carcinomas correlates with tumor progression and shortened patient survival American Journal of Pathology. 145: 301-309. PMID 7519824 |
0.378 |
|
| 1994 |
Visscher DW, Sloane B, Sakr W, Sameni M, Weaver D, Bouwman D, Crissman JD. Clinicopathologic Significance of Cathepsin B and Urokinase-type Plasminogen Activator Immunostaining in Colorectal Adenocarcinoma International Journal of Surgical Pathology. 1: 227-234. DOI: 10.1177/106689699400100403 |
0.451 |
|
| 1993 |
Sinha AA, Gleason DF, Deleon OF, Wilson MJ, Sloane BF. Localization of a biotinylated cathepsin B oligonucleotide probe in human prostate including invasive cells and invasive edges by in situ hybridization. The Anatomical Record. 235: 233-40. PMID 7678371 DOI: 10.1002/Ar.1092350207 |
0.361 |
|
| 1992 |
Moin K, Day NA, Sameni M, Hasnain S, Hirama T, Sloane BF. Human tumour cathepsin B. Comparison with normal liver cathepsin B. The Biochemical Journal. 285: 427-34. PMID 1637335 DOI: 10.1042/Bj2850427 |
0.325 |
|
| 1992 |
Buck MR, Karustis DG, Day NA, Honn KV, Sloane BF. Degradation of extracellular-matrix proteins by human cathepsin B from normal and tumour tissues. The Biochemical Journal. 282: 273-8. PMID 1540143 DOI: 10.1042/Bj2820273 |
0.407 |
|
| 1992 |
Sloane BF, Rozhin J, Moin K, Ziegler G, Fong D, Muschel RJ. Cysteine endopeptidases and their inhibitors in malignant progression of rat embryo fibroblasts. Biological Chemistry Hoppe-Seyler. 373: 589-94. PMID 1515088 DOI: 10.1515/Bchm3.1992.373.2.589 |
0.351 |
|
| 1992 |
Boike G, Lah T, Sloane BF, Rozhin J, Honn K, Guirguis R, Stracke ML, Liotta LA, Schiffman E. A possible role for cysteine proteinase and its inhibitors in motility of malignant melanoma and other tumour cells Melanoma Research. 1: 333-340. PMID 1422189 DOI: 10.1097/00008390-199201000-00004 |
0.327 |
|
| 1990 |
Sloane BF. Cathepsin B and cystatins: Evidence for a role in cancer progression Seminars in Cancer Biology. 1: 137-152. PMID 2103490 |
0.361 |
|
| 1990 |
Sloane BF, Moin K, Krepela E, Rozhin J. Cathepsin B and its endogenous inhibitors: the role in tumor malignancy Cancer and Metastasis Review. 9: 333-352. PMID 2097084 DOI: 10.1007/Bf00049523 |
0.471 |
|
| 1989 |
Lah TT, Clifford JL, Helmer KM, Day NA, Moin K, Honn KV, Crissman JD, Sloane BF. Inhibitory properties of low molecular mass cysteine proteinase inhibitors from human sarcoma. Biochimica Et Biophysica Acta. 993: 63-73. PMID 2804124 DOI: 10.1016/0304-4165(89)90144-X |
0.393 |
|
| 1989 |
Rozhin J, Wade RL, Honn KV, Sloane BF. Membrane-associated cathepsin L: a role in metastasis of melanomas. Biochemical and Biophysical Research Communications. 164: 556-61. PMID 2803319 DOI: 10.1016/0006-291X(89)91755-5 |
0.315 |
|
| 1989 |
Lah TT, Buck MR, Honn KV, Crissman JD, Rao NC, Liotta LA, Sloane BF. Degradation of laminin by human tumor cathepsin B Clinical &Amp; Experimental Metastasis. 7: 461-468. PMID 2785014 DOI: 10.1007/Bf01753666 |
0.463 |
|
| 1989 |
Fong D, Kartasova T, Sloane BF, Chan MMy. Bacterial expression of human cysteine proteinase inhibitor stefin A Febs Letters. 257: 55-58. PMID 2680606 DOI: 10.1016/0014-5793(89)81785-5 |
0.341 |
|
| 1988 |
Sloane BF, Rozhin J, Lah TT, Day NA, Buck M, Ryan RE, Crissman JD, Honn KV. Tumor cathepsin B and its endogenous inhibitors in metastasis. Advances in Experimental Medicine and Biology. 233: 259-68. PMID 3066154 |
0.325 |
|
| 1988 |
Cavanaugh PG, Sloane BF, Honn KV. Role of the coagulation system in tumor-cell-induced platelet aggregation and metastasis Haemostasis. 18: 37-46. PMID 3047022 DOI: 10.1159/000215781 |
0.41 |
|
| 1987 |
Menter DG, Hatfield JS, Harkins C, Sloane BF, Taylor JD, Crissman JC, Honn KV. Tumor cell-platelet interactions in vitro and their relationship to in vivo arrest of hematogenously circulating tumor cells Clinical &Amp; Experimental Metastasis. 5: 65-78. PMID 3829498 DOI: 10.1007/Bf00116627 |
0.414 |
|
| 1987 |
Menter DG, Sloane BF, Taylor JD, Honn KV. A New in Vitro Model for Investigation of Tumor Cell-Platelet-Endothelial Cell Interactions and Concomitant Eicosanoid Biosynthesis Cancer Research. 47: 2425-2432. PMID 3552214 |
0.311 |
|
| 1987 |
Menter DG, Sloane BF, Steinert BW, Onoda J, Craig R, Harkins C, Taylor JD, Honn KV. Platelet enhancement of tumor cell adhesion to subendothelial matrix: Role of platelet cytoskeleton and platelet membrane Journal of the National Cancer Institute. 79: 1077-1090. PMID 3479634 DOI: 10.1093/Jnci/79.5.1077 |
0.38 |
|
| 1987 |
Grossi IM, Taylor JD, Honn KV, Kendall A, Sloane BF, Fitzgerald LA. Inhibition of human tumor cell induced platelet aggregation by antibodies to platelet glycoproteins lb and llb/llla Proceedings of the Society For Experimental Biology and Medicine. 186: 378-383. PMID 3423021 DOI: 10.3181/00379727-186-3-Rc1 |
0.325 |
|
| 1987 |
Sloane BF, Rozhin J, Hatfield JS, Crissman JD, Honn KV. Plasma membrane-associated cysteine proteinases in human and animal tumors. Experimental Cell Biology. 55: 209-24. PMID 3315769 DOI: 10.1159/000163420 |
0.45 |
|
| 1987 |
Honn KV, Menter DG, Onoda JM, Steinert BW, Diglio CA, Taylor JD, Sloane BF. Tumor cell-platelet-endothelial cell interactions and prostaglandin metabolism Advances in Prostaglandin, Thromboxane, and Leukotriene Research. 17: 981-985. PMID 2960216 |
0.325 |
|
| 1987 |
Sloane BF, Rozhin J, Hatfield JS, Crissman JD, Honn KV. Plasma membrane-associated cysteine proteinases in human and animal tumors Pathobiology. 55: 209-224. DOI: 10.1159/000163420 |
0.342 |
|
| 1986 |
Onoda JM, Jacobs JR, Taylor JD, Sloane BF, Honn KV. Cisplatin and nifedipine: Synergistic cytotoxicity against murine solid tumors and their metastases Cancer Letters. 30: 181-188. PMID 3955540 DOI: 10.1016/0304-3835(86)90087-X |
0.362 |
|
| 1986 |
Sloane BF, Rozhin J, Johnson K, Taylor H, Crissman JD, Honn KV. Cathepsin B: Association with plasma membrane in metastatic tumors Proceedings of the National Academy of Sciences of the United States of America. 83: 2483-2487. PMID 3458210 DOI: 10.1073/Pnas.83.8.2483 |
0.356 |
|
| 1985 |
Crissman JD, Hatfield J, Schaldenbrand M, Sloane BF, Honn KV. Arrest and extravasation of B16 amelanotic melanoma in murine lungs. A light and electron microscopic study Laboratory Investigation. 53: 470-478. PMID 4046557 |
0.351 |
|
| 1985 |
Cavanaugh PG, Sloane BF, Bajkowski AS, Taylor JD, Honn KV. Purification and characterization of platelet aggregating activity from tumor cells: Copurification with procoagulant activity Thrombosis Research. 37: 309-326. PMID 3975874 DOI: 10.1016/0049-3848(85)90019-2 |
0.314 |
|
| 1985 |
Honn KV, Onoda JM, Pampalona K, Battaglia M, Neagos G, Taylor JD, Diglio CA, Sloane BF. Inhibition by dihydropyridine class calcium channel blockers of tumor cell-platelet-endothelial cell interactions in vitro and metastasis in vivo Biochemical Pharmacology. 34: 235-241. PMID 3966924 DOI: 10.1016/0006-2952(85)90130-3 |
0.382 |
|
| 1985 |
Ryan RE, Sloane BF, Crissman JD, Honn KV. Cathepsin B-like Activity in Viable Tumor Cells Isolated from Rodent Tumors Cancer Research. 45: 3636-3641. PMID 3893687 |
0.394 |
|
| 1984 |
Honn KV, Onoda JM, Diglio CA, Carufel MM, Taylor JD, Sloane BF. Inhibition of tumor cell-platelet interactions and tumor metastasis by the calcium channel blocker, nimodipine Clinical &Amp; Experimental Metastasis. 2: 61-72. PMID 6543691 DOI: 10.1007/Bf00132307 |
0.383 |
|
| 1984 |
Sloane BF, Honn KV. Cysteine proteinases and metastasis Cancer and Metastasis Review. 3: 249-263. PMID 6093995 DOI: 10.1007/Bf00048388 |
0.485 |
|
| 1984 |
Sloane BF, Sadler JG, Evens C. Cathepsin B-like cysteine proteinases and tumor metastasis Cancer Bulletin. 36: 196-200. |
0.329 |
|
| 1983 |
Honn KV, Onoda JM, Diglio CA, Sloane BF. Calcium Channel Blockers: Potential Antimetastatic Agents Proceedings of the Society For Experimental Biology and Medicine. 174: 16-19. PMID 6634703 DOI: 10.3181/00379727-174-1-Rc2 |
0.389 |
|
| 1983 |
Honn KV, Menter D, Cavanaugh PG, Neagos G, Moilanen D, Taylor JD, Sloane BF. A review of prostaglandins and the treatment of tumor metastasis Acta Clinica Belgica. 38: 53-67. PMID 6405568 DOI: 10.1080/22953337.1983.11718906 |
0.413 |
|
| 1983 |
Cavanaugh PG, Sloane BF, Bajkowski AS, Gasic GJ, Gasic TB, Honn KV. Involvement of a cathepsin B-like cysteine proteinase in platelet aggregation induced by tumor cells and their shed membrane vesicles Clinical &Amp; Experimental Metastasis. 1: 297-307. PMID 6400436 DOI: 10.1007/Bf00121192 |
0.387 |
|
| 1983 |
Honn KV, Busse WD, Sloane BF. Prostacyclin and thromboxanes. Implications for their role in tumor cell metastasis Biochemical Pharmacology. 32: 1-11. PMID 6338880 DOI: 10.1016/0006-2952(83)90644-5 |
0.466 |
|
| 1982 |
Sloane BF, Honn KV, Taylor JD, Sadler JG, Turner WA, Kimpson JJ. Cathepsin B Activity in B16 Melanoma Cells: A Possible Marker for Metastatic Potential Cancer Research. 42: 980-986. PMID 7059993 |
0.401 |
|
| 1982 |
Honn KV, Cavanaugh P, Evens C, Taylor JD, Sloane BF. Tumor cell-platelet aggregation: Induced by cathepsin B-like proteinase and inhibited by prostacyclin Science. 217: 540-542. PMID 7046053 DOI: 10.1126/Science.7046053 |
0.401 |
|
| 1981 |
Sloane BF, Dunn JR, Honn KV. Lysosomal cathepsin B: Correlation with metastatic potential Science. 212: 1151-1153. PMID 7233209 DOI: 10.1126/Science.7233209 |
0.483 |
|
| 1980 |
James‐Kracke MR, Sloane BF, Shuman H, Karp R, Somlyo AP. Electron probe analysis of cultured vascular smooth muscle Journal of Cellular Physiology. 103: 313-322. PMID 7440638 DOI: 10.1002/Jcp.1041030217 |
0.474 |
|
| 1979 |
Scarpa A, Valliéres J, Sloane B, Somlyo AP. Smooth muscle mitochondria. Methods in Enzymology. 55: 60-5. PMID 459858 DOI: 10.1016/0076-6879(79)55009-5 |
0.534 |
|
| 1979 |
James-Kracke MR, Sloane BF, Shuman H, Somlyo AP. Lysosomal composition in cultured vascular smooth muscle cells: Electron probe analysis Proceedings of the National Academy of Sciences of the United States of America. 76: 6461-6465. PMID 293733 DOI: 10.1073/Pnas.76.12.6461 |
0.49 |
|
| 1978 |
Sloane BF, Scarpa A, Somlyo AP. Vascular smooth muscle mitochondria: Magnesium content and transport Archives of Biochemistry and Biophysics. 189: 409-416. PMID 708060 DOI: 10.1016/0003-9861(78)90228-X |
0.537 |
|
| 1977 |
Sloane BF, Bird JW. Effect of ovarian hormones on lysosomal acid hydrolase activities in rat myometrium. The American Journal of Physiology. 232: E423-31. PMID 557904 |
0.573 |
|
| Show low-probability matches. |
